Data demonstrating decisiondx®-melanoma was a significant, independent predictor of metastatic recurrence in stage i-iii cutaneous melanoma published in future oncology

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced the publication of data demonstrating that decisiondx®-melanoma is a significant independent predictor of metastatic recurrence.

CSTL Ratings Summary

CSTL Quant Ranking